Drugs / ALRN-5281
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01775358 | Jan → May 2013 | pituitary deficiency | Aileron Therapeutics, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ALRN-5281 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01775358 ↗ |
| Route | Subcutaneous | “administered by subcutaneous injection” NCT01775358 ↗ |